Category Ranking
98%
Total Visits
921
Avg Visit Duration
2 minutes
Citations
20
Article Abstract
The rise in availability of neuroimaging has led to an increase in incidentally discovered meningiomas. These tumors are typically asymptomatic and tend to display slow growth. Treatment options include observation with serial monitoring, radiation, and surgery. Although optimal management is unclear, clinicians recommend a conservative approach, which preserves quality of life and limits unnecessary intervention. Several risk factors have been investigated for their potential utility in the development of prognostic models for risk assessment. Herein, the authors review the current literature on incidental meningiomas, focusing their discussion on potential predictive factors for tumor growth and appropriate management practices.
Download full-text PDF |
Source |
|---|---|
| http://dx.doi.org/10.1016/j.nec.2023.02.009 | DOI Listing |
Publication Analysis
Top Keywords
Similar Publications
Unraveling a Diagnostic Enigma: Navigating an Intricate Case of Spontaneous Cerebrospinal Fluid Rhinorrhea.
Maedica (Bucur)
June 2025
Department of Internal Medicine, General Hospital "G. Hatzikosta" of Ioannina, Ioannina, Greece.
Cerebrospinal fluid (CSF) rhinorrhea is a relatively rare medical condition characterized by the drainage of CSF through the nasal cavity. Cerebrospinal fluid leakage can be attributed to a plethora of different causes, mostly traumatic or iatrogenic, but it can also be spontaneous. Due to its rare entity, CSF rhinorrhea is often a diagnostic trap and can be misdiagnosed and mistreated as rhinosinusitis or allergic rhinitis.
View Article and Find Full Text PDFContrast-Enhanced Brain MRI for Ambulatory Evaluation of Headache: Comprehensive or Excessive?
AJNR Am J Neuroradiol
September 2025
From the Department of Radiology, Massachusetts General Hospital, Harvard Medical School, Boston, Massachusetts.
Background And Purpose: Headache is one of the most common indications for brain MR imaging. Our purpose was to assess the necessity and yield of contrast-enhanced brain MRI protocols relative to noncontrast protocols for the outpatient evaluation of headache in adults.
Materials And Methods: We retrospectively reviewed 874 consecutive adult outpatient brain contrast-enhanced MRIs for the indication of headache.
Core Outcome Sets for Meningioma In Clinical studies (COSMIC): An international patient and healthcare professional consensus for research studies.
Neurooncol Pract
August 2025
Department of Neurosurgery, The Walton Centre NHS Foundation Trust, Liverpool, UK.
Background: Core Outcome Sets (COS) define the minimum outcomes that should be measured and reported in all clinical trials for a specific health condition or health area. The aim was to develop 2 COS for intracranial meningioma to be used in future clinical studies: COSMIC: Intervention for effectiveness trials and COSMIC: Observation for studies of incidental/untreated meningioma.
Methods: A study advisory group was formed with representation from international stakeholder groups: EORTC BTG, ICOM, EANO, SNO, RANO-PRO, BNOS, SBNS, BIMS, TBTC, International Brain Tumour Alliance, and Brainstrust.
Diffuse Pulmonary Meningotheliomatosis: An Exceedingly Rare Disease for a Not-So-Rare Pattern.
Cureus
June 2025
Pulmonology Department, Unidade Local de Saúde Gaia/Espinho, Vila Nova de Gaia, PRT.
Diffuse pulmonary meningotheliomatosis (DPM) is a rare lung disease characterized by the proliferation of meningothelial-like cells within the pulmonary interstitium. It predominantly affects middle-aged women and is often asymptomatic, although mild respiratory symptoms may occur. Chest CT typically shows diffuse and bilateral micronodules, and histology confirms meningothelial-like nodules expressing epithelial membrane antigen (EMA), CD56, and progesterone receptor.
View Article and Find Full Text PDF